UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses

Nature immunology, 2022-12, Vol.23 (12), p.1788-1798

2022

Volltextzugriff (PDF)

Defining the risk of SARS-CoV-2 variants on immune protection

Nature (London), 2022-05, Vol.605 (7911), p.640-652

2022

Volltextzugriff (PDF)

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus

Journal of acquired immune deficiency syndromes (1999), 2013-07, Vol.63 (3), p.263-271

2013

Volltextzugriff (PDF)

β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination

The Journal of biological chemistry, 2023-12, Vol.299 (12), p.105474, Article 105474

2023

Volltextzugriff (PDF)

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial

Vaccine, 2016-11, Vol.34 (47), p.5792-5801

2016

Volltextzugriff (PDF)

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection

The New England journal of medicine, 1997-10, Vol.337 (18), p.1267-1274

1997

Volltextzugriff (PDF)

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Scientific reports, 2019-12, Vol.9 (1), p.20005-15, Article 20005

2019

Volltextzugriff (PDF)

Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in Senegal

Journal of Virology, 2004-12, Vol.78 (24), p.13934-13942

2004

Volltextzugriff (PDF)

Protection against Human Immunodeficiency Virus Type 1 Infection in Persons with Repeated Exposure: Evidence for T Cell Immunity in the Absence of Inherited CCR5 Coreceptor Defects

The Journal of infectious diseases, 1999-03, Vol.179 (3), p.548-557

1999

Volltextzugriff (PDF)

Resilient child sexual abuse survivors: Cognitive coping and illusion

Child abuse & neglect, 1996-08, Vol.20 (8), p.747-758

1996

Volltextzugriff (PDF)

Effect of Combination Antiretroviral Therapy on T-Cell Immunity in Acute Human Immunodeficiency Virus Type 1 Infection

The Journal of infectious diseases, 2000-01, Vol.181 (1), p.121-131

2000

Volltextzugriff (PDF)

Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes

Journal of Virology, 2003-01, Vol.77 (1), p.291-300

2003

Volltextzugriff (PDF)

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.290-298

1999

Volltextzugriff (PDF)

Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment

The Journal of clinical investigation, 2001-02, Vol.107 (4), p.505-517

2001

Volltextzugriff (PDF)

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.340-348

1996

Volltextzugriff (PDF)

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

The New England journal of medicine, 2021-05, Vol.384 (19), p.1824-1835

2021

Volltextzugriff (PDF)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P307-P307, Article P307

2009

Volltextzugriff (PDF)

Cell free HIV-1 virus can infect inner and outer foreskin polarized explants

Retrovirology, 2012-09, Vol.9 (S2), p.O22-O22, Article O22

2012

Volltextzugriff (PDF)

Early and Persistent Human Immunodeficiency Virus Type 1 (HIV-1)—Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV-1 Infection

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.278-284

1999

Volltextzugriff (PDF)

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

Journal of Virology, 1997-06, Vol.71 (6), p.4284-4295

1997

Volltextzugriff (PDF)

In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis

Mucosal immunology, 2016-05, Vol.9 (3), p.798-808

2016

Volltextzugriff (PDF)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting

Retrovirology, 2012-09, Vol.9 (S2), p.P137-P137, Article P137

2012

Volltextzugriff (PDF)

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Nature medicine, 2019-07, Vol.25 (7), p.1064-1072

2019

Volltextzugriff (PDF)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

Retrovirology, 2009-10, Vol.6 (S3), p.P398-P398, Article P398

2009

Volltextzugriff (PDF)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Retrovirology, 2012-09, Vol.9 (S2), p.O56-O56, Article O56

2012

Volltextzugriff (PDF)

1 – 25 von 604

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(570)
Mit Volltextzugriff
(503)

Publikationsform

Sprache

Englisch
(601)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses

Defining the risk of SARS-CoV-2 variants on immune protection

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus

β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Comparison of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses in HIV-1- and HIV-2-Infected Individuals in Senegal

Protection against Human Immunodeficiency Virus Type 1 Infection in Persons with Repeated Exposure: Evidence for T Cell Immunity in the Absence of Inherited CCR5 Coreceptor Defects

Resilient child sexual abuse survivors: Cognitive coping and illusion

Effect of Combination Antiretroviral Therapy on T-Cell Immunity in Acute Human Immunodeficiency Virus Type 1 Infection

Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes

A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?

Cell free HIV-1 virus can infect inner and outer foreskin polarized explants

Early and Persistent Human Immunodeficiency Virus Type 1 (HIV-1)—Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV-1 Infection

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Suchergebnisse filtern